Relay Therapeutics Inc

24 sept. 2026, 19:46 UTC

Relay Therapeutics shares fell amid expectations for data release, despite significant call buying and potential $400 million funding from Elevar if approved this week.

23 sept. 2026, 23:20 UTC

Relay Therapeutics Inc is gaining in after-market trading, moving from a low return to a peak, currently around the middle of its one-month trading range.

22 sept. 2026, 20:07 UTC

Relay Therapeutics Inc shares are rising sharply, benefiting from strong market momentum and remaining above their 20-day moving average since Monday's close.

21 sept. 2026, 20:06 UTC

Relay Therapeutics Inc shares fell sharply, closing near the lower end of their one-month range and significantly below the 20-day moving average.

18 sept. 2026, 20:06 UTC

Relay Therapeutics Inc shares fell sharply after an early peak, trading below its 20-day moving average and near the lower end of its one-month range.

17 sept. 2026, 19:46 UTC

Relay Therapeutics Inc is trading higher, having reached a peak earlier before pulling back, and has gained since Wednesday's close.

16 sept. 2026, 20:13 UTC

Relay Therapeutics Inc saw modestly lower trading during after-market hours, remaining unchanged since Wednesday's close and below its 20-day moving average.

15 sept. 2026, 19:46 UTC

Relay Therapeutics Inc shares are lower, reflecting negative market sentiment after the NY Empire State Manufacturing Index fell sharply to 7.6 for September.

14 sept. 2026, 20:21 UTC

Relay Therapeutics Inc. shares advanced in after-market trading, rebounding from earlier lows and reflecting a shift within a routine range since Monday's close.

10 sept. 2026, 19:16 UTC

Relay Therapeutics Inc is trading higher, recovering from an earlier dip. No specific news was identified, though broader market sentiment may be influencing shares.

9 sept. 2026, 23:31 UTC

Relay Therapeutics Inc is trading higher in after-market hours, advancing since Wednesday's close despite a broader market decline amid rising oil prices and inflation concerns.

8 sept. 2026, 20:07 UTC

Relay Therapeutics shares are higher, continuing an upward trend since Friday's close, though they remain below the 20-day moving average.

2 sept. 2026, 20:08 UTC

Relay Therapeutics will participate in two investor conferences in September 2026. Shares are trading roughly flat since Tuesday's close, below the 20-day moving average.

31 aug. 2026, 20:07 UTC

Relay Therapeutics shares are lower today amid broader market pressures and concerns about inflation following the Jackson Hole Economic Symposium.

28 aug. 2026, 21:51 UTC

Relay Therapeutics Inc is trading higher in after-market hours, rebounding from three consecutive lower sessions. No specific news was identified for this movement.

27 aug. 2026, 22:01 UTC

Relay Therapeutics Inc shares are lower in after-market trading, declining from earlier gains amid broader weakness and three consecutive sessions of losses.

26 aug. 2026, 20:08 UTC

Relay Therapeutics Inc is trading lower today amid broader market declines, influenced by inflation data that exceeded expectations and may impact Federal Reserve policy.

25 aug. 2026, 23:41 UTC

Relay Therapeutics Inc shares are lower in after-market hours, with no specific news identified for the decline. The stock remains above its 20-day moving average.

24 aug. 2026, 19:56 UTC

Relay Therapeutics is testing a buy point at $20.79, reflecting ongoing interest. The stock remains higher since Friday's close despite an earlier pullback.

21 aug. 2026, 21:01 UTC

Relay Therapeutics Inc is trading higher in after-market hours, up significantly since Friday's close and above its 20-day moving average.

20 aug. 2026, 20:02 UTC

Relay Therapeutics Inc shares are lower today, influenced by a decline in the broader Biotechnology sector and significant market volatility. Trading volume remains unusually high.

19 aug. 2026, 23:01 UTC

Relay Therapeutics Inc is trading higher in after-market hours, positioned near the upper end of its one-month range and above its 20-day moving average.

18 aug. 2026, 22:26 UTC

Relay Therapeutics Inc. shares traded lower after market hours, reflecting broader market pressure from rising bond yields and inflation concerns.

17 aug. 2026, 19:36 UTC

Relay Therapeutics Inc is trading higher amid a Phase 3 trial for its breast cancer treatment and a $53 million investment from Baker Bros.

14 aug. 2026, 21:51 UTC

Relay Therapeutics Inc is gaining in after-market trading, supported by social media discussions and a significant portfolio stake from Perceptive Advisors.

13 aug. 2026, 19:16 UTC

Relay Therapeutics Inc is trading lower, reflecting broader declines in the biotechnology sector amid fluctuations and rising initial jobless claims.

10 aug. 2026, 19:56 UTC

Relay Therapeutics shares are higher after Citizens raised its price target to $26, citing confidence in the company's Phase 3 trials.

7 aug. 2026, 20:06 UTC

Barclays raised its price target on Relay Therapeutics to $30.00, contributing to positive sentiment amid ongoing analyst support following the company's Q2 earnings.

6 aug. 2026, 23:02 UTC

Relay Therapeutics shares are lower in after-market hours following disappointing Q2 results, including a net loss of $83.7 million and revenue of $350,000.

5 aug. 2026, 22:26 UTC

Relay Therapeutics Inc. shares advanced in after-market trading, maintaining a position above its 20-day moving average amid broader macroeconomic sentiment.